You just read:

Research and Markets - Global Biosimilar Pipeline and Market Prospects 2017-2022: Focus on Basaglar, Inflectra, Benepali, Rituximab, Trastuzumab, Adalimumab and Bevacizumab

News provided by

Research and Markets

Apr 20, 2017, 07:00 ET